Novel Developments in Angiogenesis Cancer Therapy
Department of Medical Oncology, Juravinski Cancer Centre, 699 Concession Street, Hamilton, ON L8V 5C2, Canada
Curr. Oncol. 2009, 16(3), 50-54; https://doi.org/10.3747/co.v16i3.444
Submission received: 11 February 2009
/
Revised: 5 March 2009
/
Accepted: 4 April 2009
/
Published: 1 May 2009
Abstract
A greater understanding of the factors and pathways controlling angiogenesis in tumours has allowed the development of a number of agents that selectively inhibit the pathways mediating that activity. The results to date of clinical trials with such agents and future research opportunities are reviewed.
Keywords:
angiogenesis; targeted therapy; combination therapy
Share and Cite
MDPI and ACS Style
Hirte, H.W. Novel Developments in Angiogenesis Cancer Therapy. Curr. Oncol. 2009, 16, 50-54. https://doi.org/10.3747/co.v16i3.444
AMA Style
Hirte HW. Novel Developments in Angiogenesis Cancer Therapy. Current Oncology. 2009; 16(3):50-54. https://doi.org/10.3747/co.v16i3.444
Chicago/Turabian StyleHirte, Hal W. 2009. "Novel Developments in Angiogenesis Cancer Therapy" Current Oncology 16, no. 3: 50-54. https://doi.org/10.3747/co.v16i3.444
